CN112485448A - Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 - Google Patents
Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 Download PDFInfo
- Publication number
- CN112485448A CN112485448A CN202011310340.6A CN202011310340A CN112485448A CN 112485448 A CN112485448 A CN 112485448A CN 202011310340 A CN202011310340 A CN 202011310340A CN 112485448 A CN112485448 A CN 112485448A
- Authority
- CN
- China
- Prior art keywords
- nmi
- cap
- severity
- patients
- prognosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011310340.6A CN112485448B (zh) | 2020-11-20 | 2020-11-20 | Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011310340.6A CN112485448B (zh) | 2020-11-20 | 2020-11-20 | Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112485448A true CN112485448A (zh) | 2021-03-12 |
CN112485448B CN112485448B (zh) | 2021-08-24 |
Family
ID=74932422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011310340.6A Active CN112485448B (zh) | 2020-11-20 | 2020-11-20 | Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112485448B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294339B1 (en) * | 2000-10-10 | 2001-09-25 | Richard Glenn Wunderink | Method of diagnosing and treating increased risk of death from community-acquired pneumonia associated with the a allele of the TNFα-238 polymorphism |
US20020086016A1 (en) * | 2000-10-10 | 2002-07-04 | Wunderink Richard Glenn | Method for indentifying increased risk of death from community acquired pneumonia |
CN108778333A (zh) * | 2016-03-14 | 2018-11-09 | 生物测试股份公司 | 严重社区获得性肺炎的治疗 |
CN111599465A (zh) * | 2020-05-13 | 2020-08-28 | 上海森亿医疗科技有限公司 | 儿童社区获得性肺炎病原学类型预测方法、装置、终端及介质 |
-
2020
- 2020-11-20 CN CN202011310340.6A patent/CN112485448B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294339B1 (en) * | 2000-10-10 | 2001-09-25 | Richard Glenn Wunderink | Method of diagnosing and treating increased risk of death from community-acquired pneumonia associated with the a allele of the TNFα-238 polymorphism |
US20020086016A1 (en) * | 2000-10-10 | 2002-07-04 | Wunderink Richard Glenn | Method for indentifying increased risk of death from community acquired pneumonia |
CN108778333A (zh) * | 2016-03-14 | 2018-11-09 | 生物测试股份公司 | 严重社区获得性肺炎的治疗 |
US20190076523A1 (en) * | 2016-03-14 | 2019-03-14 | Biotest Ag | Treatment of severe community acquired pneumonia |
CN111599465A (zh) * | 2020-05-13 | 2020-08-28 | 上海森亿医疗科技有限公司 | 儿童社区获得性肺炎病原学类型预测方法、装置、终端及介质 |
Non-Patent Citations (4)
Title |
---|
JIANCHANG WANG ET AL: "A critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis", 《VIRUS RES》 * |
LIFU XIONG ET AL: "N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus", 《JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY》 * |
MIRJAM CHRIST-CRAIN ET AL: "Clinical review: the role of biomarkers in the diagnosis and management of communityacquired pneumonia", 《CRIT CARE》 * |
MIRJAM CHRIST-CRAIN ET AL: "Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia", 《CRIT CARE.》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112485448B (zh) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6108409B2 (ja) | 播種性血管内凝固症候群または感染性播種性血管内凝固症候群を検出する方法 | |
US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
Chen et al. | Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis. | |
Melki et al. | Circulating Interferon‐α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al | |
Molnar et al. | Relationship between C-reactive protein and early activation of leukocytes indicated by leukocyte antisedimentation rate (LAR) in patients with acute cerebrovascular events | |
CN112485448B (zh) | Nmi蛋白作为生物靶标在制备成人社区获得性肺炎严重程度及预后评估试剂盒的应用 | |
CN109891241B (zh) | 能够进行糖尿病性肾病的早期病情的特异性诊断的检查方法 | |
CN113252896B (zh) | 一款利用肺泡灌洗液中nd1预测急性呼吸窘迫综合征预后的试剂盒 | |
CN111060694B (zh) | 一种用于血管炎性高血压联合诊断试剂盒及其应用 | |
EP2853896A2 (en) | A method and apparatus for obtaining an information related to eosinophilic airway inflammation | |
CN114015773A (zh) | 全身炎症反应指数在胃肠道弥漫性大b细胞淋巴瘤预后评估中的应用 | |
CN112285360A (zh) | I-309在制备原发性干燥综合征诊断试剂或试剂盒中的应用 | |
US20200116736A1 (en) | Methods for Diagnosing and Treating Subjects for Pulmonary Exacerbation | |
EP4177608A1 (en) | Biomarker panel for diagnosing pulmonary dysfunction | |
US20230296628A1 (en) | Biomarkers for Identifying Relapses in Multiple Sclerosis | |
WO2021213291A1 (zh) | 病毒感染的血液学参数 | |
US20230146286A1 (en) | Protein diagnostic biomarker for severe drug eruption | |
Noreldina et al. | Sirtuin-1 in Rheumatoid Arthritis Patients, Relation to Disease Activity and Interleukin-17A | |
Zhang et al. | Prognostic value of Th1/Th2/Th17-related cytokines in severe pneumonia | |
Martin et al. | 181* Development of a novel tool for the rapid detection of neutrophil elastase as a marker of inflammation within the clinic | |
CN116218991A (zh) | RabGGTase在ALS病情严重程度和病情进展率诊断中的应用 | |
Ali et al. | Study of Interleukin-17 and Fc Gamma Receptor in SLE Patients and Its Relation to Disease Activity and Clinical Presentation | |
Liu et al. | Urinary Galectin-3 and CXCL-7 as biomarkers for diagnosing interstitial cystitis and correlation with clinical characteristics | |
Li et al. | Salivary Biomarkers in the Diagnosis of Sjogren’s Syndrome: A Review of Current Research Progress | |
Shakoor et al. | Diagnostic Accuracy of Serum Presepsin as Biomarker of Bacterial Sepsis in Paediatric Patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Feng Inventor after: OuYang Wei Inventor after: He Teng Inventor after: Pan Ying Inventor after: Xu Zhijiang Inventor after: Zhang Wanying Inventor after: Lin Xiuhui Inventor after: Chen Jie Inventor after: Lu Huidan Inventor after: Zhou Hui Inventor after: Xia Lexin Inventor after: Xia Jingyan Inventor after: Cen Mengyuan Inventor before: Xu Feng Inventor before: OuYang Wei Inventor before: He Teng Inventor before: Pan Ying Inventor before: Xu Zhijiang Inventor before: Zhang Wanying Inventor before: Lin Xiuhui Inventor before: Chen Jie Inventor before: Lu Huidan Inventor before: Zhou Hui Inventor before: Xia Lexin Inventor before: Xia Jingyan Inventor before: Cen Mengyuan |
|
GR01 | Patent grant | ||
GR01 | Patent grant |